Director/PDMR Shareholding
Source: RNS
1 March 2024
Oryx International Growth Fund Limited
(the "Company")
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
On 29 February 2024, North Atlantic Smaller Companies Investment Trust PLC ("NASCIT"), a Person Closely Associated with Mr Christopher Mills (Director of the Company), purchased 6,500 shares in the Company.
Following this transaction, NASCIT will have an interest in the Company's Ordinary Shares of 7,423,500 shares.
The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details:
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a) |
Name |
1) Christopher Mills 2) NASCIT |
||||
|
2 |
Reason for the notification |
|||||
|
a)
|
Position/status |
1) Director 2) PCA
|
||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a)
|
Name
|
Oryx International Growth Fund Limited |
||||
|
b)
|
LEI
|
213800W5W6THP34TW941 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares
ISIN : GG00B3BTVQ94
|
||||
|
b)
|
Nature of the transaction |
Purchase |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume - Price
|
6,500 £11.47300000 |
||||
|
e)
|
Date of the transaction
|
29 February 2024 |
||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
